Clinical Trial Update: Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 dose-finding and dose-expansion study of OSE-279 in adults with advanced solid tumors or lymphomas, currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Non-small Cell Lung Cancer
• Solid Tumor

Drugs mentioned

• OSE-279

Snippet

Sponsor: OSE Immunotherapeutics | Conditions: Solid Advanced Tumor, Lymphoma | Phase 1, Phase 2 | Status: RECRUITING